Newsroom

Sorted by: Latest

-

LMR、Tonka Bean CO₂ Absoluteを発表:環境配慮型の抽出で引き出すグルマンの魅力

フランス、グラース--(BUSINESS WIRE)--(ビジネスワイヤ) -- IFF(NYSE:IFF)のLMR Naturals by IFFは香水・化粧品・フレーバー向け天然原料のグローバルリーダーで有名ですが、同社は香水・フレーバー向けに高い持続可能性とトレーサビリティを備えた天然原料12種で構成される「Conscious Collection」に、Tonka Bean CO₂ Absoluteを新たに追加しましたTonka Bean CO₂ Absoluteはグルマン調の香り立ちを持つ天然エキスです。調香の新たな選択肢となる本原料は、フランスのオーブラックにあるIFF抽出拠点で、再生可能なCO₂と回収・再利用した超臨界CO2を用いて製造されています。 LMR Naturals by IFFのゼネラルマネジャーであるベルトラン・ド・プレヴィル氏は次のように述べています。「オーブラックのCO₂抽出設備があったからこそ、LMRは持続可能性香りとしての高い魅力(官能性)”を自然に両立させた抽出物のコレクションを形にできました。Tonka Bean CO₂ Absoluteの投入は...
-

DISCO Announces All-Inclusive Platform for eDiscovery

AUSTIN, Texas--(BUSINESS WIRE)--DISCO (NYSE: LAW), a creator of industry-leading litigation technology, today announced an all-new, all-inclusive solution for litigation, investigations and regulatory responses, designed to put its market-leading eDiscovery and AI tools in a single platform at a single, transparent price. The new DISCO offering combines its eDiscovery, Cecilia AI, deposition management and timelines capabilities into a powerful platform to give customers one-stop access to some...
-

BioMed Realty’s Gateway of Pacific Earns BOMA TOBY Award for Excellence in Life Science Operations

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--BioMed Realty, the largest private operator of real estate for the life science and technology industries, today announced that its Gateway of Pacific campus in South San Francisco has been named a local winner of the BOMA TOBY (The Outstanding Building of the Year) Award in the Life Science category. Presented by the Building Owners and Managers Association (BOMA), the TOBY Awards are among the most respected and comprehensive recognitions in comme...
-

Deutsche Bank AG UK Regulatory Announcement: Issuance of Securities

LONDON--(BUSINESS WIRE)--  DB ETC PLC Dated: 25 February 2026 COMPANY ANNOUNCEMENT Immediate Release 25 February 2026 DB ETC plc (the Issuer) Law 1991 (as amended) with registered number 103781) Re: Issuance of ETC Securities Announcement The Issuer has agreed to issue ETC Securities for the following Series as set out in the table below. Series Tranche Number of Securities to be issued Trade Date Settlement Date ISIN: Series 04 - Xtrackers Physical Silver EUR Hedged ETC 410 1,300 23 February 2...
-

Cicada Raises US$13.5 Million Series A to Modernize Local-Currency Latin American Bond Trading

NEW YORK--(BUSINESS WIRE)--U.S.-regulated fintech Cicada closed a US$13.5 million Series A led by Citi to bring electronic trading to Latin American local-currency bond markets....
-

MCM Energy Partners Completes Acquisition of Delaware Basin Crude Oil and Natural Gas Assets From Battalion Oil Corporation

MIDLAND, Texas--(BUSINESS WIRE)--MCM Delaware Resources LLC, a subsidiary of MCM Energy Partners (“MCM”), announced today that it has closed the acquisition of crude oil and natural gas assets from Battalion Oil Corporation (“Battalion”). This acquisition represents a significant step in MCM’s strategy to build a premier, multi-bench development platform in the core of the Permian Basin, one of the most economic and robust oil and gas regions in North America. In conjunction with the closing of...
-

Pinnacle West Reports 2025 Full-Year and Fourth-Quarter Results

PHOENIX--(BUSINESS WIRE)--Pinnacle West 2025 financial results positively impacted by robust customer and sales growth....
-

Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen®

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the broadening of its NAD+ precursor intellectual property (IP) portfolio with the newly granted U.S. Patent No. 12,558,367, which covers the methods of use of nicotinamide riboside (NR) and derivatives in intravenous and injectable formulations. Rob Fried, CEO of Niagen Bioscience, commented, “This p...
-

Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, will present at the 46th Annual TD Cowen Healthcare Conference. Vistagen’s President and Chief Executive Officer, Shawn Singh, will present a corporate overview on Monday, March 2, 2026, at 3:50 p.m. Eastern Time. A replay of the w...
-

Atlanta Hawks Foundation and Ressler Gertz Family Foundation Advance Prostate Cancer Awareness with $150,000 Gift

ATLANTA--(BUSINESS WIRE)--During last night’s game presented by Emory Healthcare, the Atlanta Hawks Foundation, together with the Ressler Gertz Family Foundation, announced a $150,000 donation to the Prostate Cancer Foundation (PCF) reinforcing their shared commitment to increasing awareness of prostate cancer and supporting critical research initiatives. This season, the Atlanta Hawks Foundation pledged a donation of $75,000 to the Prostate Cancer Foundation, a leading organization dedicated t...